Nifty

:

25571.25

Sensex

:

82814.71

116.90 (0.46%)
316.57 (0.38%)

Login

Nifty
Sensex

:
:

25571.25
82814.71

116.90 (0.46%)
316.57 (0.38%)

Syncom Formulations (India) Ltd.

Pharmaceuticals & Drugs

Rating :

60/99

BSE: 524470 | NSE: SYNCOMF

Watchlist

NSE BSE

13.11

19-Feb-2026

Open
High
Low
Previous Close

13.6
13.6
13.06
13.59

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1266747
16836240.98
23.49
11.65

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,232.34
17.87
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,231.76
N/A
3.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.72
13.59
27.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.50
7.06
22.16

PAT CAGR (%)

10 Years
5 Years
3 Years

16.91
10.87
35.05

P:E (Median)

8 Years
5 Years
3 Years

37.02
53.63
42.95

P:BV (Average)

8 Years
5 Years
3 Years

1.65
2.53
4.22

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.38
32.43
28.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 114.59 127.03 -9.79% 121.43 101.49 19.65% 116.55 86.83 34.23% 148.46 73.27 102.62%
Expenses 93.42 112.43 -16.91% 102.71 89.56 14.68% 100.77 76.36 31.97% 130.99 64.46 103.21%
EBITDA 21.17 14.60 45.00% 18.72 11.93 56.92% 15.77 10.47 50.62% 17.47 8.80 98.52%
EBIDTM 18.48% 11.49% 15.42% 11.75% 13.54% 12.06% 11.77% 12.02%
Other Income 5.48 3.83 43.08% 5.23 4.18 25.12% 6.02 1.31 359.54% 6.90 2.87 140.42%
Interest 0.25 0.21 19.05% 0.25 0.16 56.25% 0.24 0.39 -38.46% 0.09 1.17 -92.31%
Depreciation 1.36 1.31 3.82% 1.35 1.30 3.85% 1.34 1.30 3.08% 1.29 1.30 -0.77%
PBT 25.05 16.90 48.22% 22.36 14.65 52.63% 20.26 10.10 100.59% 23.01 9.21 149.84%
Tax 6.19 4.11 50.61% 5.52 3.70 49.19% 4.53 2.47 83.40% 5.51 2.46 123.98%
PAT 18.86 12.79 47.46% 16.84 10.95 53.79% 15.73 7.63 106.16% 17.50 6.75 159.26%
PATM 16.46% 10.07% 13.87% 10.79% 13.50% 8.79% 11.79% 9.21%
EPS 0.20 0.14 42.86% 0.18 0.12 50.00% 0.17 0.08 112.50% 0.19 0.07 171.43%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 115.14 127.53 -9.72% 121.72 102.31 18.97% 116.90 87.25 33.98% 148.88 74.57 99.65%
Expenses 93.93 112.80 -16.73% 103.32 90.15 14.61% 101.09 76.80 31.63% 131.12 65.15 101.26%
EBITDA 21.21 14.73 43.99% 18.40 12.16 51.32% 15.81 10.45 51.29% 17.75 9.42 88.43%
EBIDTM 18.42% 11.55% 15.12% 11.89% 13.52% 11.98% 11.92% 12.64%
Other Income 5.50 4.04 36.14% 5.25 4.15 26.51% 6.04 1.34 350.75% 6.94 3.10 123.87%
Interest 0.26 0.20 30.00% 0.27 0.16 68.75% 0.25 0.39 -35.90% 0.12 1.19 -89.92%
Depreciation 1.36 1.31 3.82% 1.35 1.30 3.85% 1.34 1.30 3.08% 1.29 1.30 -0.77%
PBT 25.09 17.26 45.37% 22.04 14.85 48.42% 20.29 10.10 100.89% 23.30 10.03 132.30%
Tax 6.18 4.26 45.07% 5.44 3.74 45.45% 4.54 2.47 83.81% 5.61 2.63 113.31%
PAT 18.91 13.00 45.46% 16.60 11.11 49.41% 15.75 7.63 106.42% 17.69 7.40 139.05%
PATM 16.42% 10.19% 13.64% 10.86% 13.48% 8.75% 11.89% 9.93%
EPS 0.20 0.14 42.86% 0.18 0.12 50.00% 0.17 0.08 112.50% 0.19 0.08 137.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 501.03 462.85 258.36 224.64 219.66 244.81 205.51 186.77 158.63 184.82 183.90 Net Sales Growth 28.93% 79.15% 15.01% 2.27% -10.27% 19.12% 10.03% 17.74% -14.17% 0.50% Cost Of Goods Sold 301.01 267.02 116.32 101.08 105.70 120.38 117.67 107.49 80.82 102.80 106.54 Gross Profit 200.02 195.83 142.04 123.56 113.96 124.42 87.84 79.28 77.81 82.03 77.36 GP Margin 39.92% 42.31% 54.98% 55.00% 51.88% 50.82% 42.74% 42.45% 49.05% 44.38% 42.07% Total Expenditure 427.89 409.34 230.51 204.76 199.63 206.76 188.72 174.93 146.93 168.42 167.23 Power & Fuel Cost - 5.62 6.13 5.31 4.38 3.84 3.93 3.63 3.40 3.01 2.69 % Of Sales - 1.21% 2.37% 2.36% 1.99% 1.57% 1.91% 1.94% 2.14% 1.63% 1.46% Employee Cost - 50.56 33.57 24.44 20.73 18.24 15.80 15.21 14.77 14.33 13.48 % Of Sales - 10.92% 12.99% 10.88% 9.44% 7.45% 7.69% 8.14% 9.31% 7.75% 7.33% Manufacturing Exp. - 42.51 41.34 44.08 36.93 42.97 35.87 30.15 29.64 26.74 27.01 % Of Sales - 9.18% 16.00% 19.62% 16.81% 17.55% 17.45% 16.14% 18.68% 14.47% 14.69% General & Admin Exp. - 23.91 19.73 15.00 14.06 9.13 8.73 9.00 9.15 9.13 8.36 % Of Sales - 5.17% 7.64% 6.68% 6.40% 3.73% 4.25% 4.82% 5.77% 4.94% 4.55% Selling & Distn. Exp. - 19.17 12.81 14.29 17.32 11.91 6.42 9.14 8.84 12.09 8.90 % Of Sales - 4.14% 4.96% 6.36% 7.88% 4.86% 3.12% 4.89% 5.57% 6.54% 4.84% Miscellaneous Exp. - 0.55 0.61 0.56 0.50 0.29 0.31 0.31 0.31 0.31 8.90 % Of Sales - 0.12% 0.24% 0.25% 0.23% 0.12% 0.15% 0.17% 0.20% 0.17% 0.14% EBITDA 73.13 53.51 27.85 19.88 20.03 38.05 16.79 11.84 11.70 16.40 16.67 EBITDA Margin 14.60% 11.56% 10.78% 8.85% 9.12% 15.54% 8.17% 6.34% 7.38% 8.87% 9.06% Other Income 23.63 17.19 13.10 14.61 11.99 7.14 5.22 5.08 4.44 3.08 2.67 Interest 0.83 0.85 4.45 3.40 1.93 0.48 0.61 0.25 0.30 0.36 0.14 Depreciation 5.34 5.19 4.72 4.54 3.95 4.03 4.06 4.00 3.73 3.12 3.00 PBT 90.68 64.65 31.78 26.55 26.15 40.67 17.34 12.68 12.12 16.00 16.20 Tax 21.75 15.79 8.14 6.50 6.39 11.53 3.04 1.59 3.37 5.34 5.75 Tax Rate 23.99% 24.42% 25.63% 24.47% 24.42% 28.33% 17.58% 12.54% 28.04% 33.40% 35.71% PAT 68.93 48.87 23.62 20.07 19.79 29.17 14.25 11.09 8.65 10.65 10.36 PAT before Minority Interest 68.93 48.87 23.62 20.07 19.79 29.17 14.25 11.09 8.65 10.65 10.36 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.76% 10.56% 9.14% 8.93% 9.01% 11.92% 6.93% 5.94% 5.45% 5.76% 5.63% PAT Growth 80.82% 106.90% 17.69% 1.41% -32.16% 104.70% 28.49% 28.21% -18.78% 2.80% EPS 0.73 0.52 0.25 0.21 0.21 0.31 0.15 0.12 0.09 0.11 0.11

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Net Sales 502.64 465.01 263.39 224.25 219.66 184.82 183.90 173.39 Net Sales Growth 28.34% 76.55% 17.45% 2.09% 18.85% 0.50% 6.06% Cost Of Goods Sold 301.33 267.47 117.65 100.65 105.70 102.80 106.54 84.41 Gross Profit 201.31 197.55 145.74 123.60 113.96 82.03 77.36 88.98 GP Margin 40.05% 42.48% 55.33% 55.12% 51.88% 44.38% 42.07% 51.32% Total Expenditure 429.46 410.88 233.74 204.35 199.63 168.27 167.23 155.18 Power & Fuel Cost - 5.62 6.13 5.31 4.38 3.01 2.69 2.76 % Of Sales - 1.21% 2.33% 2.37% 1.99% 1.63% 1.46% 1.59% Employee Cost - 50.56 33.57 24.44 20.73 14.45 13.48 13.38 % Of Sales - 10.87% 12.75% 10.90% 9.44% 7.82% 7.33% 7.72% Manufacturing Exp. - 42.51 41.34 44.08 36.93 26.74 27.01 33.14 % Of Sales - 9.14% 15.70% 19.66% 16.81% 14.47% 14.69% 19.11% General & Admin Exp. - 23.97 19.77 15.02 14.06 8.86 8.36 7.54 % Of Sales - 5.15% 7.51% 6.70% 6.40% 4.79% 4.55% 4.35% Selling & Distn. Exp. - 20.20 14.68 14.29 17.32 12.09 8.90 13.72 % Of Sales - 4.34% 5.57% 6.37% 7.88% 6.54% 4.84% 7.91% Miscellaneous Exp. - 0.55 0.61 0.56 0.50 0.31 0.26 0.23 % Of Sales - 0.12% 0.23% 0.25% 0.23% 0.17% 0.14% 0.13% EBITDA 73.17 54.13 29.65 19.90 20.03 16.55 16.67 18.21 EBITDA Margin 14.56% 11.64% 11.26% 8.87% 9.12% 8.95% 9.06% 10.50% Other Income 23.73 17.43 13.53 14.60 11.99 2.79 2.67 1.98 Interest 0.90 0.86 4.47 3.40 1.93 0.33 0.14 0.29 Depreciation 5.34 5.19 4.72 4.54 3.95 3.12 3.00 3.40 PBT 90.72 65.51 33.98 26.56 26.15 15.89 16.20 16.49 Tax 21.77 16.08 8.64 6.50 6.39 5.34 5.75 5.88 Tax Rate 24.00% 24.54% 25.44% 24.46% 24.42% 33.63% 35.71% 37.62% PAT 68.95 49.43 25.31 20.07 19.79 10.53 10.36 9.76 PAT before Minority Interest 68.95 49.43 25.31 20.07 19.79 10.53 10.36 9.76 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.72% 10.63% 9.61% 8.95% 9.01% 5.70% 5.63% 5.63% PAT Growth 76.16% 95.30% 26.11% 1.41% 87.94% 1.64% 6.15% EPS 0.73 0.53 0.27 0.21 0.21 0.11 0.11 0.10

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 339.90 286.45 256.01 222.22 187.58 145.65 132.62 121.94 114.14 108.70 Share Capital 94.00 94.00 94.00 86.25 79.00 78.07 78.07 78.07 78.07 78.07 Total Reserves 245.90 192.45 162.01 130.94 98.84 67.58 54.56 43.88 36.08 30.63 Non-Current Liabilities 11.81 10.00 8.66 7.76 7.36 7.11 7.57 9.37 8.33 6.27 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.17 3.30 2.69 1.71 1.39 1.21 0.74 0.69 0.60 0.00 Current Liabilities 60.38 97.28 112.27 78.26 96.70 31.18 35.82 42.70 56.36 65.68 Trade Payables 42.72 14.23 20.41 13.79 29.30 20.30 21.16 22.31 32.26 46.94 Other Current Liabilities 7.09 5.72 6.07 2.83 3.12 3.36 1.22 3.40 5.85 3.67 Short Term Borrowings 4.04 71.65 83.18 57.79 62.09 2.15 8.67 12.45 12.45 5.62 Short Term Provisions 6.53 5.69 2.61 3.85 2.19 5.38 4.76 4.54 5.80 9.46 Total Liabilities 412.09 393.73 376.94 308.24 291.64 183.94 176.01 174.01 178.83 180.65 Net Block 77.57 72.42 43.40 46.61 44.32 45.98 48.35 57.55 55.04 45.85 Gross Block 145.62 135.66 101.92 100.68 95.18 92.91 91.31 97.63 91.98 82.41 Accumulated Depreciation 68.05 63.25 58.53 54.07 50.86 46.92 42.96 40.08 36.94 36.56 Non Current Assets 142.22 128.86 196.17 168.44 101.81 94.54 94.69 92.60 92.29 89.10 Capital Work in Progress 0.00 0.00 25.59 6.20 0.38 0.00 0.00 0.64 0.25 4.72 Non Current Investment 3.65 2.52 1.87 1.93 1.17 0.63 1.51 2.04 1.28 23.47 Long Term Loans & Adv. 1.20 1.01 2.26 2.25 1.10 0.79 4.34 0.95 5.89 15.05 Other Non Current Assets 12.47 5.58 75.73 64.33 7.70 0.00 0.28 0.00 0.15 0.00 Current Assets 269.88 264.87 180.77 139.80 189.84 89.40 81.32 81.41 86.55 91.55 Current Investments 89.22 63.70 62.26 41.40 9.89 0.00 0.00 0.00 0.00 0.00 Inventories 41.29 21.08 20.77 19.51 22.56 16.07 13.72 11.04 10.01 15.47 Sundry Debtors 106.94 93.21 75.14 67.55 74.82 43.34 41.33 37.70 45.99 46.00 Cash & Bank 0.69 67.83 8.58 0.39 64.20 8.57 7.87 6.27 7.27 5.69 Other Current Assets 31.73 1.30 4.46 2.73 18.37 21.42 18.40 26.40 23.27 24.39 Short Term Loans & Adv. 28.50 17.75 9.56 8.23 11.36 16.34 12.27 22.42 13.52 18.41 Net Current Assets 209.49 167.59 68.50 61.54 93.14 58.22 45.50 38.71 30.18 25.87 Total Assets 412.10 393.73 376.94 308.24 291.65 183.94 176.01 174.01 178.84 180.65

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Shareholder's Funds 342.16 288.14 256.01 222.22 117.35 108.70 100.22 Share Capital 94.00 94.00 94.00 86.25 78.07 78.07 78.07 Total Reserves 248.16 194.14 162.01 130.94 39.29 30.63 22.16 Non-Current Liabilities 11.81 10.00 8.66 7.76 7.73 6.27 5.62 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.17 3.30 2.69 1.71 0.00 0.00 0.00 Current Liabilities 61.78 108.76 113.16 78.26 58.84 65.69 36.66 Trade Payables 42.80 24.14 20.45 13.79 32.27 46.94 19.92 Other Current Liabilities 7.75 6.26 6.91 2.83 5.84 3.67 1.63 Short Term Borrowings 4.58 72.49 83.18 57.79 12.45 5.62 6.08 Short Term Provisions 6.66 5.86 2.62 3.85 8.27 9.46 9.04 Total Liabilities 415.75 406.90 377.83 308.24 183.92 180.66 142.50 Net Block 77.57 72.42 43.40 46.61 55.04 45.85 45.78 Gross Block 145.62 135.66 101.92 100.68 91.98 82.41 80.43 Accumulated Depreciation 68.05 63.25 58.53 54.07 36.94 36.56 34.65 Non Current Assets 143.31 129.88 196.14 168.44 97.38 88.99 58.91 Capital Work in Progress 0.00 0.00 25.59 6.20 0.25 4.72 0.00 Non Current Investment 3.62 2.49 1.84 1.93 35.91 23.37 6.38 Long Term Loans & Adv. 1.20 1.01 2.26 2.25 6.18 15.05 6.75 Other Non Current Assets 13.59 6.63 75.73 64.33 0.00 0.00 0.00 Current Assets 272.44 277.01 181.69 139.80 86.54 91.66 83.59 Current Investments 89.22 63.70 62.26 41.40 0.00 0.00 0.00 Inventories 41.33 21.08 21.20 19.51 10.01 15.47 10.94 Sundry Debtors 107.55 103.30 75.51 67.55 45.99 46.00 31.16 Cash & Bank 0.71 67.87 8.63 0.39 6.52 5.69 6.77 Other Current Assets 33.63 1.48 4.46 2.73 24.01 24.50 34.72 Short Term Loans & Adv. 30.14 19.59 9.63 8.23 17.53 18.41 25.47 Net Current Assets 210.66 168.26 68.53 61.54 27.70 25.98 46.93 Total Assets 415.75 406.89 377.83 308.24 183.92 180.65 142.50

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 23.31 -5.94 10.50 16.33 -2.06 5.86 4.33 -1.60 16.90 24.07 PBT 64.65 31.78 26.55 26.15 40.67 17.34 12.68 12.12 16.00 16.10 Adjustment -10.97 -3.27 -6.12 -7.16 -2.10 -1.05 -0.74 -0.28 0.22 1.14 Changes in Working Capital -15.92 -26.87 -3.28 3.58 -29.34 -5.99 -4.17 -10.37 4.71 12.29 Cash after chg. in Working capital 37.77 1.64 17.14 22.57 9.24 10.30 7.77 1.47 20.94 29.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.45 -7.58 -6.65 -6.25 -11.30 -4.43 -3.44 -3.07 -4.03 -5.35 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.10 Cash From Investing Activity -18.38 83.83 -44.97 -27.07 -75.35 1.51 2.44 -2.16 -8.43 -22.74 Net Fixed Assets -9.96 -8.15 -20.63 -11.32 -2.65 -1.60 6.96 -6.04 -5.10 -6.70 Net Investments -26.65 -2.09 -20.80 -32.27 -10.43 0.88 0.53 -0.76 22.19 -16.99 Others 18.23 94.07 -3.54 16.52 -62.27 2.23 -5.05 4.64 -25.52 0.95 Cash from Financing Activity -67.59 -15.37 35.00 8.29 71.96 -6.52 -0.18 -2.05 -2.09 -2.40 Net Cash Inflow / Outflow -62.66 62.52 0.53 -2.45 -5.46 0.86 6.59 -5.81 6.38 -1.08 Opening Cash & Equivalents 63.35 0.83 0.30 2.75 8.21 7.35 0.76 6.57 0.19 6.77 Closing Cash & Equivalent 0.69 63.35 0.83 0.30 2.75 8.21 7.35 0.76 6.57 5.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 23.44 -5.96 10.53 16.33 13.84 24.07 0.08 PBT 65.51 33.98 26.56 26.15 15.88 16.10 16.49 Adjustment -11.19 -3.48 -6.11 -7.16 0.71 1.14 2.59 Changes in Working Capital -16.13 -28.37 -3.26 3.58 1.29 12.29 -12.51 Cash after chg. in Working capital 38.18 2.13 17.18 22.58 17.88 29.53 6.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.74 -8.08 -6.65 -6.25 -4.03 -5.35 -5.64 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -0.01 -0.10 -0.86 Cash From Investing Activity -18.20 83.02 -44.95 -27.07 -17.68 -22.74 0.74 Net Fixed Assets -9.96 -8.15 -20.63 -14.65 -5.10 -6.70 Net Investments -26.65 -2.09 -20.80 -42.05 22.19 -16.99 Others 18.41 93.26 -3.52 29.63 -34.77 0.95 Cash from Financing Activity -67.90 -14.56 35.00 8.29 4.67 -2.40 0.68 Net Cash Inflow / Outflow -62.67 62.50 0.58 -2.45 0.83 -1.08 1.50 Opening Cash & Equivalents 63.38 0.88 0.30 2.75 5.69 6.77 5.28 Closing Cash & Equivalent 0.71 63.38 0.88 0.30 6.52 5.69 6.77

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 3.62 3.05 2.72 2.52 2.25 1.87 1.70 1.56 1.46 1.39 ROA 12.13% 6.13% 5.86% 6.60% 12.27% 7.92% 6.34% 4.90% 5.93% 6.41% ROE 15.61% 8.71% 8.48% 10.02% 18.04% 10.24% 8.71% 7.33% 9.56% 9.91% ROCE 18.66% 10.39% 9.68% 10.61% 20.72% 12.39% 9.37% 9.43% 13.58% 14.72% Fixed Asset Turnover 3.29 2.17 2.22 2.24 2.60 2.23 1.98 1.67 2.12 2.28 Receivable days 78.92 118.92 115.92 118.29 88.09 75.19 77.22 96.24 90.83 75.88 Inventory Days 24.59 29.57 32.72 34.95 28.80 26.46 24.19 24.20 25.15 25.97 Payable days 38.93 54.35 61.75 74.40 75.18 40.43 46.30 70.08 91.34 73.89 Cash Conversion Cycle 64.59 94.14 86.89 78.83 41.70 61.22 55.12 50.35 24.64 27.96 Total Debt/Equity 0.01 0.25 0.32 0.27 0.35 0.01 0.07 0.10 0.11 0.05 Interest Cover 77.05 8.14 8.81 14.58 86.35 29.18 52.62 41.40 45.48 119.10

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 3.64 3.07 2.72 2.52 1.50 1.39 1.28 1.22 1.12 ROA 12.02% 6.45% 5.85% 8.04% 5.78% 6.41% 6.82% 6.95% 4.54% ROE 15.69% 9.30% 8.48% 11.83% 9.32% 9.91% 9.99% 10.19% 6.45% ROCE 18.77% 10.98% 9.68% 13.72% 13.28% 14.72% 15.55% 15.29% 10.00% Fixed Asset Turnover 3.31 2.22 2.21 2.28 2.12 2.28 2.20 2.00 1.55 Receivable days 82.75 123.89 116.42 94.33 90.83 75.88 63.71 70.22 91.86 Inventory Days 24.50 29.30 33.13 24.52 25.15 25.97 21.92 19.22 19.28 Payable days 45.68 69.17 62.08 79.52 91.28 73.89 59.55 67.54 70.98 Cash Conversion Cycle 61.57 84.02 87.47 39.33 24.70 27.96 26.08 21.90 40.17 Total Debt/Equity 0.01 0.25 0.32 0.27 0.11 0.05 0.06 0.03 0.02 Interest Cover 76.75 8.59 8.81 14.58 48.48 119.10 54.58 30.75 17.10

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Syncom Formulations - Quarterly Results
13th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback